US Stock MarketDetailed Quotes

XFORW X4 PHARMACEUTICALS INC C/WTS 16/04/24(TO PUR COM) CL A

Watchlist
  • 0.001
  • 0.0000.00%
15min DelayClose Apr 9 16:00 ET
0Market Cap0.00P/E (TTM)

X4 PHARMACEUTICALS INC C/WTS 16/04/24(TO PUR COM) CL A Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-25.17%-96.51M
-45.33%-27.75M
-7.88%-20.83M
-15.97%-21.43M
-31.06%-26.51M
-8.74%-77.1M
-0.21%-19.09M
-35.85%-19.31M
3.77%-18.47M
-9.68%-20.23M
Net income from continuing operations
-7.78%-101.17M
34.27%-19.13M
89.32%-2.31M
-162.64%-55.71M
-9.36%-24.02M
-5.83%-93.87M
3.65%-29.1M
-6.99%-21.59M
-8.02%-21.21M
-17.61%-21.97M
Operating gains losses
-345.54%-7.07M
---6.33M
---25.16M
--29.86M
---5.44M
687.16%2.88M
----
----
----
----
Depreciation and amortization
-18.32%419K
-50.00%62K
-16.13%104K
-4.55%126K
-4.51%127K
2.81%513K
-6.06%124K
-6.06%124K
2.33%132K
25.47%133K
Other non cash items
-6.44%2.28M
11.08%471K
-45.87%636K
55.98%613K
25.90%559K
-2.01%2.44M
-31.06%424K
44.00%1.18M
-15.30%393K
-24.87%444K
Change In working capital
-94.00%344K
-197.86%-5.36M
2,823.08%3.54M
123.73%1.55M
305.33%616K
482.91%5.74M
512.90%5.48M
-103.71%-130K
135.45%691K
82.59%-300K
-Change in prepaid assets
-124.59%-1.37M
-138.15%-1.83M
96.98%-20K
-97.66%-1.61M
27.62%2.08M
65.24%-610K
55.89%-768K
-135.38%-663K
31.01%-812K
329.68%1.63M
-Change in payables and accrued expense
-60.68%2.84M
-150.52%-3.24M
397.17%3.87M
96.62%3.43M
28.23%-1.22M
612.82%7.23M
900.63%6.4M
-57.23%778K
374.06%1.74M
-109.77%-1.7M
-Change in other current assets
--0
----
----
----
----
--0
----
----
----
----
-Change in other current liabilities
-27.89%-1.13M
-82.61%-294K
-25.71%-308K
-15.00%-276K
-5.93%-250K
-26.36%-882K
28.44%-161K
-26.94%-245K
-100.00%-240K
-47.50%-236K
Cash from discontinued investing activities
Operating cash flow
-25.17%-96.51M
-45.33%-27.75M
-7.88%-20.83M
-15.97%-21.43M
-31.06%-26.51M
-8.74%-77.1M
-0.21%-19.09M
-35.85%-19.31M
3.77%-18.47M
-9.68%-20.23M
Investing cash flow
Cash flow from continuing investing activities
-14,349.51%-14.88M
-14,114.71%-4.83M
-57,200.00%-5.16M
-12,752.63%-4.88M
59.09%-9K
83.25%-103K
-161.54%-34K
55.00%-9K
55.81%-38K
95.56%-22K
Net PPE purchase and sale
41.75%-60K
-2.94%-35K
11.11%-8K
78.95%-8K
59.09%-9K
83.25%-103K
-161.54%-34K
55.00%-9K
55.81%-38K
95.56%-22K
Net investment purchase and sale
---14.82M
---4.8M
---5.15M
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
-14,349.51%-14.88M
-14,114.71%-4.83M
-57,200.00%-5.16M
-12,752.63%-4.88M
59.09%-9K
83.25%-103K
-161.54%-34K
55.00%-9K
55.81%-38K
95.56%-22K
Financing cash flow
Cash flow from continuing financing activities
-24.49%88.52M
-99.84%97K
-59.20%21.21M
20,082.13%69.34M
-142.86%-2.12M
57.90%117.23M
146.82%60.64M
1,270.13%51.98M
62.45%-347K
-91.00%4.96M
Net issuance payments of debt
2,670.57%20.44M
--0
4,938.04%22.12M
--0
-84.93%-1.68M
---795K
--0
--439K
---325K
---909K
Net common stock issuance
-51.07%60M
--0
-116.24%-8.9M
315,272.73%69.34M
-107.54%-443K
65.75%122.63M
153.44%62.01M
1,332.96%54.77M
97.88%-22K
-89.31%5.88M
Proceeds from stock option exercised by employees
4,088.46%8.71M
-78.82%728K
----
----
----
-20.00%208K
3,237.86%3.44M
----
----
----
Net other financing activities
86.89%-631K
----
----
----
----
---4.81M
---4.8M
--0
--0
---12K
Cash from discontinued financing activities
Financing cash flow
-24.49%88.52M
-99.84%97K
-59.20%21.21M
20,082.13%69.34M
-142.86%-2.12M
57.90%117.23M
146.82%60.64M
1,270.13%51.98M
62.45%-347K
-91.00%4.96M
Net cash flow
Beginning cash position
48.03%123.03M
63.41%132.6M
182.35%137.46M
39.40%94.43M
48.03%123.03M
2.98%83.11M
4.41%81.15M
-49.55%48.68M
-41.93%67.74M
2.98%83.11M
Current changes in cash
-157.16%-22.88M
-178.24%-32.48M
-114.63%-4.78M
328.16%43.03M
-87.28%-28.65M
1,368.81%40.03M
654.31%41.52M
274.92%32.66M
6.67%-18.86M
-142.37%-15.3M
Effect of exchange rate changes
194.29%99K
-65.01%127K
63.45%-72K
97.03%-6K
172.46%50K
67.08%-105K
412.93%363K
-97.00%-197K
-605.00%-202K
51.75%-69K
End cash Position
-18.52%100.25M
-18.52%100.25M
63.41%132.6M
182.35%137.46M
39.40%94.43M
48.03%123.03M
48.03%123.03M
4.41%81.15M
-49.55%48.68M
-41.93%67.74M
Free cash flow
-25.09%-96.57M
-45.25%-27.78M
-7.87%-20.84M
-15.78%-21.43M
-30.96%-26.52M
-7.95%-77.21M
-0.32%-19.13M
-35.72%-19.32M
4.00%-18.51M
-6.92%-20.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -25.17%-96.51M-45.33%-27.75M-7.88%-20.83M-15.97%-21.43M-31.06%-26.51M-8.74%-77.1M-0.21%-19.09M-35.85%-19.31M3.77%-18.47M-9.68%-20.23M
Net income from continuing operations -7.78%-101.17M34.27%-19.13M89.32%-2.31M-162.64%-55.71M-9.36%-24.02M-5.83%-93.87M3.65%-29.1M-6.99%-21.59M-8.02%-21.21M-17.61%-21.97M
Operating gains losses -345.54%-7.07M---6.33M---25.16M--29.86M---5.44M687.16%2.88M----------------
Depreciation and amortization -18.32%419K-50.00%62K-16.13%104K-4.55%126K-4.51%127K2.81%513K-6.06%124K-6.06%124K2.33%132K25.47%133K
Other non cash items -6.44%2.28M11.08%471K-45.87%636K55.98%613K25.90%559K-2.01%2.44M-31.06%424K44.00%1.18M-15.30%393K-24.87%444K
Change In working capital -94.00%344K-197.86%-5.36M2,823.08%3.54M123.73%1.55M305.33%616K482.91%5.74M512.90%5.48M-103.71%-130K135.45%691K82.59%-300K
-Change in prepaid assets -124.59%-1.37M-138.15%-1.83M96.98%-20K-97.66%-1.61M27.62%2.08M65.24%-610K55.89%-768K-135.38%-663K31.01%-812K329.68%1.63M
-Change in payables and accrued expense -60.68%2.84M-150.52%-3.24M397.17%3.87M96.62%3.43M28.23%-1.22M612.82%7.23M900.63%6.4M-57.23%778K374.06%1.74M-109.77%-1.7M
-Change in other current assets --0------------------0----------------
-Change in other current liabilities -27.89%-1.13M-82.61%-294K-25.71%-308K-15.00%-276K-5.93%-250K-26.36%-882K28.44%-161K-26.94%-245K-100.00%-240K-47.50%-236K
Cash from discontinued investing activities
Operating cash flow -25.17%-96.51M-45.33%-27.75M-7.88%-20.83M-15.97%-21.43M-31.06%-26.51M-8.74%-77.1M-0.21%-19.09M-35.85%-19.31M3.77%-18.47M-9.68%-20.23M
Investing cash flow
Cash flow from continuing investing activities -14,349.51%-14.88M-14,114.71%-4.83M-57,200.00%-5.16M-12,752.63%-4.88M59.09%-9K83.25%-103K-161.54%-34K55.00%-9K55.81%-38K95.56%-22K
Net PPE purchase and sale 41.75%-60K-2.94%-35K11.11%-8K78.95%-8K59.09%-9K83.25%-103K-161.54%-34K55.00%-9K55.81%-38K95.56%-22K
Net investment purchase and sale ---14.82M---4.8M---5.15M----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow -14,349.51%-14.88M-14,114.71%-4.83M-57,200.00%-5.16M-12,752.63%-4.88M59.09%-9K83.25%-103K-161.54%-34K55.00%-9K55.81%-38K95.56%-22K
Financing cash flow
Cash flow from continuing financing activities -24.49%88.52M-99.84%97K-59.20%21.21M20,082.13%69.34M-142.86%-2.12M57.90%117.23M146.82%60.64M1,270.13%51.98M62.45%-347K-91.00%4.96M
Net issuance payments of debt 2,670.57%20.44M--04,938.04%22.12M--0-84.93%-1.68M---795K--0--439K---325K---909K
Net common stock issuance -51.07%60M--0-116.24%-8.9M315,272.73%69.34M-107.54%-443K65.75%122.63M153.44%62.01M1,332.96%54.77M97.88%-22K-89.31%5.88M
Proceeds from stock option exercised by employees 4,088.46%8.71M-78.82%728K-------------20.00%208K3,237.86%3.44M------------
Net other financing activities 86.89%-631K-------------------4.81M---4.8M--0--0---12K
Cash from discontinued financing activities
Financing cash flow -24.49%88.52M-99.84%97K-59.20%21.21M20,082.13%69.34M-142.86%-2.12M57.90%117.23M146.82%60.64M1,270.13%51.98M62.45%-347K-91.00%4.96M
Net cash flow
Beginning cash position 48.03%123.03M63.41%132.6M182.35%137.46M39.40%94.43M48.03%123.03M2.98%83.11M4.41%81.15M-49.55%48.68M-41.93%67.74M2.98%83.11M
Current changes in cash -157.16%-22.88M-178.24%-32.48M-114.63%-4.78M328.16%43.03M-87.28%-28.65M1,368.81%40.03M654.31%41.52M274.92%32.66M6.67%-18.86M-142.37%-15.3M
Effect of exchange rate changes 194.29%99K-65.01%127K63.45%-72K97.03%-6K172.46%50K67.08%-105K412.93%363K-97.00%-197K-605.00%-202K51.75%-69K
End cash Position -18.52%100.25M-18.52%100.25M63.41%132.6M182.35%137.46M39.40%94.43M48.03%123.03M48.03%123.03M4.41%81.15M-49.55%48.68M-41.93%67.74M
Free cash flow -25.09%-96.57M-45.25%-27.78M-7.87%-20.84M-15.78%-21.43M-30.96%-26.52M-7.95%-77.21M-0.32%-19.13M-35.72%-19.32M4.00%-18.51M-6.92%-20.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data